Acknowledgements We gratefully acknowledge the technical
assistance of Maria Silvandira Franc¸a Pinheiro and Jose
´
Ivan Rodri-
gues de Sousa.
References
1. Bartlett JG (2002) Clinical practice. Antibiotic-associated diar-
rhea. N Engl J Med 346:334–339
2. Kelly CP, Pothoulakis C, LaMont JT (1994) Clostridium difficile
colitis. N Engl J Med 330:257–262
3. Kyne L, Warny M, Qamar A, Kelly CP (2000) Asymptomatic
carriage of Clostridium difficile and serum levels of IgG antibody
against toxin A. N Engl J Med 342:390–397
4. Just I, Wilm M, Selzer J, Rex G, von Eichel-Streiber C, Mann M,
Aktories K (1995) The enterotoxin from Clostridium difficile
(ToxA) monoglucosylates the Rho proteins. J Biol Chem
270:13932–13936
5. Just I, Selzer J, von Eichel-Streiber C, Aktories K (1995) The low
molecular mass GTP-binding protein Rho is affected by toxin A
from Clostridium difficile. J Clin Invest 95:1026–1031
6. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Ak-
tories K (1995) Glucosylation of Rho proteins by Clostridium
difficile toxin B. Nature 375:500–503
7. Popoff MR, Rubin EJ, Gill DM, Boquet P (1988) Actin-specific
ADP-ribosyltransferase produced by a Clostridium difficile strain.
Infect Immun 56:2299–2306
8. Rubin MS, Bodenstein LE, Kent KC (1995) Severe Clostridium
difficile colitis. Dis Colon Rectum 38:350–354
9. Archibald LK, Banerjee SN, Jarvis WR (2004) Secular trends in
hospital-acquired Clostridium difficile disease in the United
States, 1987–2001. J Infect Dis 189:1585–1589
10. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM,
Lee KK, Simmons RL (2002) Fulminant Clostridium difficile:an
underappreciated and increasing cause of death and complica-
tions. Ann Surg 235:363–372
11. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K,
Posey K, Roberts T, Croyle K, Krystofiak S, Patel-Brown S,
Pasculle AW, Paterson DL, Saul M, Harrison LH (2005) A large
outbreak of Clostridium difficile-associated disease with an
unexpected proportion of deaths and colectomies at a teaching
hospital following increased fluoroquinolone use. Infect Control
Hosp Epidemiol 26:273–280
12. McEllistrem MC, Carman RJ, Gerding DN, Genheimer CW,
Zheng L (2005) A hospital outbreak of Clostridium difficile dis-
ease associated with isolates carrying binary toxin genes. Clin
Infect Dis 40:265–272
13. Johnson S, Samore MH, Farrow KA, Killgore GE, Tenover FC,
Lyras D, Rood JI, DeGirolami P, Baltch AL, Rafferty ME, Pear
SM, Gerding DN (1999) Epidemics of diarrhea caused by a
clindamycin-resistant strain of Clostridium difficile in four hos-
pitals. N Engl J Med 341:1645–1651
14. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Ka-
zakova SV, Sambol SP, Johnson S, Gerding DN (2005) An
epidemic, toxin gene-variant strain of Clostridium difficile.N
Engl J Med 353:2433–2441
15. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J,
Frost E, McDonald LC (2005) Toxin production by an emerging
strain of Clostridium difficile associated with outbreaks of
severe disease in North America and Europe. Lancet 366:1079–
1084
16. Spigaglia P, Mastrantonio P (2002) Molecular analysis of the
pathogenicity locus and polymorphism in the putative negative
regulator of toxin production (TcdC) among Clostridium difficile
clinical isolates. J Clin Microbiol 40:3470–3475
17. Spigaglia P, Mastrantonio P (2004) Comparative analysis of
Clostridium difficile clinical isolates belonging to different
genetic lineages and time periods. J Med Microbiol 53:1129–
1136
18. Berteau O, Mulloy B (2003) Sulfated fucans, fresh perspectives:
structures, functions, and biological properties of sulfated fucans
and an overview of enzymes active toward this class of poly-
saccharide. Glycobiology 13:29R–40R
19. Parkin J, Cohen B (2001) An overview of the immune system.
Lancet 357:1777–1789
20. Shimaoka M, Ikeda M, Iida T, Taenaka N, Yoshiya I, Honda T
(1996) Fucoidin, a potent inhibitor of leukocyte rolling, prevents
neutrophil influx into phorbol-ester-induced inflammatory sites in
rabbit lungs. Am J Respir Crit Care Med 153:307–311
21. Castagliuolo I, Riegler M, Pasha A, Nikulasson S, Lu B, Gerard
C, Gerard NP, Pothoulakis C (1998) Neurokinin-1 (NK-1)
receptor is required in Clostridium difficile- induced enteritis. J
Clin Invest 101:1547–1550
22. Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O’Keane JC,
Snider RM, Leeman SE (1994) CP-96,345, a substance P
antagonist, inhibits rat intestinal responses to Clostridium difficile
toxin A but not cholera toxin. Proc Natl Acad Sci U S A 91:947–
951
23. Souza MH, Troncon LE, Cunha FQ, Oliveira RB (2003)
Decreased gastric tone and delayed gastric emptying precede
neutrophil infiltration and mucosal lesion formation in indo-
methacin-induced gastric damage in rats. Braz J Med Biol Res
36:1383–1390
24. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein
measurement with the Folin phenol reagent. J Biol Chem
193:265–275
25. Giusti G (1974) Adenosine deaminase. In: Bergmeyer HU (ed).
Methods of enzymatic analysis. Academic, New York, pp 1092–
1099
26. Lasky LA (1995) Selectin-carbohydrate interactions and the ini-
tiation of the inflammatory response. Annu Rev Biochem
64:113–139
27. Brito GA, Fujji J, Carneiro-Filho BA, Lima AA, Obrig T, Gu-
errant RL (2002) Mechanism of Clostridium difficile toxin A-
induced apoptosis in T84 cells. J Infect Dis 186:1438–1447
28. Alcantara CS, Jin XH, Brito GA, Carneiro-Filho BA, Barrett LJ,
Carey RM, Guerrant RL (2005) Angiotensin II subtype 1 receptor
blockade inhibits Clostridium difficile toxin A-induced intestinal
secretion in a rabbit model. J Infect Dis 191:2090–2096
29. Humphrey CD, Condon CW, Cantey JR, Pittman FE (1979)
Partial purification of a toxin found in hamsters with antibiotic-
associated colitis. Reversible binding of the toxin by cholestyr-
amine. Gastroenterology 76:468–476
30. Lima AA, Innes DJ Jr, Chadee K, Lyerly DM, Wilkins TD,
Guerrant RL (1989) Clostridium difficile toxin A. Interactions
with mucus and early sequential histopathologic effects in rabbit
small intestine. Lab Invest 61:419–425
31. Lima AA, Lyerly DM, Wilkins TD, Innes DJ, Guerrant RL
(1988) Effects of Clostridium difficile toxins A and B in rabbit
small and large intestine in vivo and on cultured cells in vitro.
Infect Immun 56:582–588
32. Lyerly DM, Krivan HC, Wilkins TD (1988) Clostridium difficile:
its disease and toxins. Clin Microbiol Rev 1:1–18
33. Lyerly DM, Lockwood DE, Richardson SH, Wilkins TD (1982)
Biological activities of toxins A and B of Clostridium difficile.
Infect Immun 35:1147–1150
34. Rehg JE (1980) Cecal toxin(s) from guinea pigs with clindamy-
cin-associated colitis, neutralized by Clostridium sordellii
antitoxin. Infect Immun 27:387–390
35. Brito GA, Sullivan GW, Ciesla WP Jr, Carper HT, Mandell GL,
Guerrant RL (2002) Clostridium difficile toxin A alters in vitro-
Dig Dis Sci (2008) 53:990–996 995
123